BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 31255453)

  • 1. Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population.
    Zhou J; Liew D; Duffy SJ; Walton A; Htun N; Stub D
    Int J Cardiol; 2019 Nov; 294():17-22. PubMed ID: 31255453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan.
    Kobayashi J; Baron SJ; Takagi K; Thompson CA; Jiao X; Yamabe K
    J Med Econ; 2024; 27(1):697-707. PubMed ID: 38654415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis.
    Zhou JY; Liew D; Duffy SJ; Walton A; Htun N; Stub D
    Heart Lung Circ; 2021 Apr; 30(4):547-554. PubMed ID: 33189571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.
    Tam DY; Hughes A; Wijeysundera HC; Fremes SE
    Ann Thorac Surg; 2018 Sep; 106(3):676-683. PubMed ID: 29730344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singapore.
    See-Toh RS; Wong XY; Mahboobani KSKH; Soon SS; Kearns B; Cooper K; Ho KW; Kuntjoro I; Ng K
    BMC Health Serv Res; 2022 Aug; 22(1):994. PubMed ID: 35927703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.
    Tam DY; Hughes A; Fremes SE; Youn S; Hancock-Howard RL; Coyte PC; Wijeysundera HC
    J Thorac Cardiovasc Surg; 2018 May; 155(5):1978-1988.e1. PubMed ID: 29454487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients.
    Mennini FS; Meucci F; Pesarini G; Vandoni P; Lettino M; Sarmah A; Shore J; Green M; Giardina S
    Int J Cardiol; 2022 Jun; 357():26-32. PubMed ID: 35306028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(14):1-148. PubMed ID: 33240455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(19):1-94. PubMed ID: 27990197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(2):1-121. PubMed ID: 32194880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk.
    Kuck KH; Leidl R; Frankenstein L; Wahlers T; Sarmah A; Candolfi P; Shore J; Green M
    Adv Ther; 2023 Mar; 40(3):1031-1046. PubMed ID: 36622552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    Reynolds MR; Lei Y; Wang K; Chinnakondepalli K; Vilain KA; Magnuson EA; Galper BZ; Meduri CU; Arnold SV; Baron SJ; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    J Am Coll Cardiol; 2016 Jan; 67(1):29-38. PubMed ID: 26764063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of heart-team-guided treatment decisions in high-risk patients with aortic valve stenosis in a health-economic context with limited resources for transcatheter valve therapies.
    Bakelants E; Belmans A; Verbrugghe P; Adriaenssens T; Jacobs S; Bennett J; Meuris B; Desmet W; Rega F; Herijgers P; Herregods MC; Dubois CL
    Acta Cardiol; 2019 Dec; 74(6):489-498. PubMed ID: 30507297
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan.
    Kodera S; Kiyosue A; Ando J; Komuro I
    J Cardiol; 2018 Mar; 71(3):223-229. PubMed ID: 29153740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation.
    Orlando R; Pennant M; Rooney S; Khogali S; Bayliss S; Hassan A; Moore D; Barton P
    Health Technol Assess; 2013 Aug; 17(33):1-86. PubMed ID: 23948359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment.
    Inoue S; Nakao K; Hanyu M; Hayashida K; Shibahara H; Kobayashi M; Asaoka M; Nishikawa K; Clancy S; Koshiishi J; Sakamaki H
    Value Health Reg Issues; 2020 May; 21():82-90. PubMed ID: 31670112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France.
    Gilard M; Eltchaninoff H; Iung B; Lefèvre T; Spaulding C; Dumonteil N; Mutuon P; Roussel C; Candolfi P; de Pouvourville G; Green M; Shore J
    Value Health; 2022 Apr; 25(4):605-613. PubMed ID: 35365304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.